课题基金 / 基金详情

项目摘要

项目成果

M. SAEED SHEIKH的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Cells are constantly exposed to a variety of environmental agents some of which induce DNA damage i.e. genotoxic stress and cellular ability to effectively manage such stresses starts to decline with age. Cellular responses to DNA damage (genotoxic stress) are complex and therefore, more studies are needed to better understand the mechanisms that control such responses. We propose to characterize a novel gene, which we have named PDRG (p53 and DNA damage-regulated gene). PDRG mRNA is differentially regulated by genotoxic stress and p53 and is overexpressed in primary colorectal tumors when compared with matching normal tissues. By yeast two-hybrid screening, we have identified three important proteins including PDCD7, CIZ1 and MAP1S that exhibit interactions with PDRG. These three proteins have been involved in modulating cell cycle and/or apoptosis suggesting that PDRG may also play a role in regulating these processes. We, therefore, hypothesize that PDRG is an important mediator of cellular response to genotoxic stress and alterations in PDRG expression and PDRG-mediated signaling events are part of the mechanisms underlying the development and/or progression of digestive diseases such as colorectal cancer. Here we propose two specific aims to further characterize PDRG. Specific Aim 1 is to investigate the role of PDRG in cellular response to genotoxic stress in p53-positive and -negative cells. Specific Aim 2 is to determine the molecular basis of PDRG interactions with PDCD7, CIZ1 and MAP1S in context to genotoxic stress response. The outcome of these studies will help to determine the potential role of PDRG in digestive diseases such as colorectal malignancies and thereby further improve our understanding of the pathobiology and toxicology of human digestive diseases. Public Health Relevance Statement: A variety of environmental agents induce DNA damage i.e. genotoxic stress and cellular ability to effectively manage such stresses starts to decline with age and that is why various tumors are more common in the elderly. Here we propose to characterize a novel p53 and DNA damage-regulated gene that exhibits altered expression in human colorectal tumors. The outcome of these studies will help to determine the potential role of PDRG in diseases such as colorectal tumors and thereby further improve our understanding of the pathobiology and toxicology of human digestive diseases.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
Sulindac Sulfide Differentially Induces Apoptosis in Smac-Proficient and -Deficient Human Colon Cancer Cells.
Sulindac Sulfide 差异性地诱导 Smac 充足和缺乏的人结肠癌细胞凋亡。
DOI: 10.4255/mcpharmacol.09.11
发表时间: 2009
期刊: Molecular and cellular pharmacology
影响因子: --
作者: [Shi,Jingxue, He,Qin, An,Jie, Sun,Hong, Huang,Ying, Sheikh,MSaeed]
通讯作者: Sheikh,MSaeed
DOI: --
发表时间: 2010
期刊: Molecular and cellular pharmacology
影响因子: --
作者: [Lingyan Jiang;M. Sheikh;Ying Huang]
通讯作者: Lingyan Jiang;M. Sheikh;Ying Huang
DOI: --
发表时间: 2010
期刊: Molecular and cellular pharmacology
影响因子: --
作者: [Qin He;Jingxue Shi;Hong Sun;J. An;Ying Huang;M. Sheikh]
通讯作者: Qin He;Jingxue Shi;Hong Sun;J. An;Ying Huang;M. Sheikh
DOI: 10.4255/mcpharmacol.10.04
发表时间: 2010
期刊: Molecular and cellular pharmacology
影响因子: --
作者: [Shi J, Huang Y, Sheikh MS]
通讯作者: Sheikh MS
Development of dihydroartemisinin as a novel preventive agent for prostate cancer
  • 批准号:
    8050362
  • 项目类别:
  • 资助金额:
    $7.96万
  • 财政年份:
    2011
  • 负责人:
    M. SAEED SHEIKH
  • 依托单位:
Development of dihydroartemisinin as a novel preventive agent for prostate cancer
  • 批准号:
    8242022
  • 项目类别:
  • 资助金额:
    $7.98万
  • 财政年份:
    2011
  • 负责人:
    M. SAEED SHEIKH
  • 依托单位:
A novel biomarker and therapeutic target for breast cancer
  • 批准号:
    8220835
  • 项目类别:
  • 资助金额:
    $17.35万
  • 财政年份:
    2011
  • 负责人:
    M. SAEED SHEIKH
  • 依托单位:
A novel biomarker and therapeutic target for breast cancer
  • 批准号:
    8062885
  • 项目类别:
  • 资助金额:
    $20.73万
  • 财政年份:
    2011
  • 负责人:
    M. SAEED SHEIKH
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: